Navigation Links
IRB Barcelona to coordinate two European projects on biomedicine
Date:12/23/2008

The Institute for Research in Biomedicine (IRB Barcelona) has been chosen by the European Commission (EC) to coordinate two European health research projects, as part of the second call of the VII Framework Programme. This concession makes IRB Barcelona a leader in European projects in Spain, together with the Spanish National Research Council. In all, Spanish centres will be heading ten projects. The EC will grant IRB Barcelona funding of more than 5 million euros from 2009 to 2011. Malaria and diabetes will be the topics addressed by the consortia headed by the researchers Llus Ribas de Pouplana and Antonio Zorzano.

DISARMING THE PARASITE THAT CAUSES MALARIA

The consortium coordinated by Llus Ribas de Pouplana, ICREA researcher and head of the Gene Translation Laboratory at IRB Barcelona, will explore a promising line of investigation to find new anti-malarial compounds. The project, called Mephitis, is included in the call "Projects for diseases of the Third World in collaboration with laboratories in India". Malaria is caused by the parasite Plasmodium falciparum, which is carried by some female Anopheles mosquitoes. Infection is via a mosquito bite, which introduces the parasite into our bodies, where it attacks red blood cells. At present, between 300 and 500 million infections are reported worldwide each year and more than a million people die from malaria every year, mainly children in Africa and Asia.

The project seeks to elucidate the formation of proteins in the parasite that are involved the transmission of malaria, with the aim to identify the key components that inhibit this process and allow the development of anti-malarial drugs. The rationale behind Ribas de Pouplana's project is that "we now have enough knowledge about protein synthesis in organisms such as the bacteria E.coli or the yeast Saccharomyces cerevisiae, and we now want to transfer this knowledge base to organisms of medical relevance such as Plasmodium". This new strategy will provide crucial information to "fight effectively against the parasite".

Ribas has brought together experts from several fields: Plasmodium biology, protein synthesis processes, and advanced tools used in crystallography, bioinformatics, genome dynamics, transcriptomics and proteomics. The Combinatorial Chemistry Programme of the Barcelona Science Park, the centre that hosts IRB Barcelona, is managed by the researcher Miriam Royo and is one of the eight laboratories included in the consortium. In addition to the two groups in Barcelona, there are two from India, one from France, one from Italy, one from Portugal and one from Australia.

BIOINFORMATICS AND MOLECULAR MEDICINE, UNITED AGAINST DIABETES

Antonio Zorzano, head of the Molecular Medicine Programme at IRB Barcelona and senior professor at the University of Barcelona, will coordinate a pioneering project to fight against diabetes, a disease described as the epidemic of the XXI century. The MITIN Project is innovative because it will be the first time that bioinformatics is applied to obtain information about complex diseases such as diabetes, which is the result of a combination of environmental and genetic factors. "Systems biology", explains Zorzano, "can hold and integrate many data about a single disease and can reveal the existence of gene networks and interactions between proteins that are responsible for the key alterations in a disease".

The six groups that comprise the consortia seek to identify the processes that occur in mitochrondria an intracellular organelle that transforms molecules from the food we ingest into energy -, and that are responsible for insulin resistance. Insulin is a hormone generated by the pancreas and serves to allow glucose to enter cells. People who suffer from the so-called Insulin Resistance Syndrome generally present high levels of triglycerides (fats) in blood and low levels of healthy cholesterol. Furthermore, hypertension and obesity may be behind insulin resistance. This metabolic disorder increases the risk of suffering from diabetes and coronary disease.

To develop the project, Zorzano is supported by two expert groups in systems biology. One is from the Barcelona Supercomputing Center, a facility that hosts the MareNostrum supercomputer, one of the most powerful in the world. This group will work on designing a computational programme that includes experimental data. The second group, from Finland, has expertise in the technique called lipidomics, which allows the determination of fat composition in body tissues and fluids. The four remaining laboratories, two in England, one in Germany and Zorzano's own lab, will apply their experience to the study of insulin resistance and diabetes in two animal models, the mouse and the fruit fly (Drosophila melanogaster), and to the manipulation of individual mammalian cells. "We will work at distinct levels of complexity and with two animal models to discover whether systems biology is a suitable approach to answer questions related to complex diseases. It is a huge challenge and if we obtain positive results, systems biology will become a key technique in future research into these types of disease", explains the project's coordinator.


'/>"/>

Contact: Snia Armengou
sonia.armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert

Related biology news :

1. Researchers at IRB Barcelona produce more data on key genes in diabetes
2. Barcelona Declaration 2008: Challenges and Pathways to Earth Sustainability
3. Caltech researchers get first look at how groups of cells coordinate their movements
4. Top scientific meeting urges coordinated response to economic and environmental crises
5. Scientists identify a molecule that coordinates the movement of cells
6. European ancestry increases breast cancer risk among Latinas
7. Overfishing threatens European bluefin tuna
8. European biodiversity and ecosystem scientists merge and gear up for long-term research
9. The MDS foundation supports vidazas recommendation for European approval
10. Vidaza receives positve opinion from European CHMP
11. European researchers harness unique properties of boron to develop new drugs and diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 The field of Human Microbiome ... most popular hubs of the biotechnology industry. While ... studies of human microbiota, have garnered a lot ... microbiome space has literally exploded in terms of ... report focuses on biomedical aspects of research, development, ...
(Date:2/3/2016)... India , February 3, 2016 ... the new market research report "Automated Fingerprint Identification System ... Search, Latent Search), Application (Banking & Finance, Government, Healthcare, ... published by MarketsandMarkets, the market is expected to be ... CAGR of 21.0% between 2015 and 2020. The transformation ...
(Date:2/3/2016)... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) ... "Emotion Detection and Recognition Market by Technology ... Tools (Facial Expression, Voice Recognition and Others), ... Global forecast to 2020" report to ... ) has announced the addition of the ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... ... 11, 2016 , ... Global Stem Cells Group, ... Global Stem Cells Network (GSCN) to distribute exosome injection and other biological products ... Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El Salvador, Venezuela, Peru, Ecuador, ...
(Date:2/10/2016)... NX Prenatal Inc., a US based ... for early warning of adverse pregnancy outcomes, announced ... by Dr. Thomas McElrath of Brigham ... Medicine,s (SMFM) annual meeting held in ... The presentation reported initial positive top-line results regarding ...
(Date:2/10/2016)... 2016  Matchbook, Inc., a company specializing in ... companies, announced today the appointment of Jim ... brings nearly 25 years of experience in supply ... nearly two decades in executive level roles as ... Genzyme and, most recently headed global logistics and ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... Testing (PROMPT), a research registry built on the secure online PatientCrossroads platform, has ... More than 1,600 participants have joined the PROMPT study, which seeks to advance ...
Breaking Biology Technology: